Sentinel lymph node mapping in endometrial cancer: an updated review Abstract

Jacqueline HS LEE 1, Joshua JX LI 2
1 Department of Obstetrics and Gynaecology, Faculty of Medicine, The Chinese University of Hong Kong
2 Department of Anatomical and Cellular Pathology, Faculty of Medicine, The Chinese University of Hong Kong

Sentinel lymph node mapping (SLNM) is widely used in staging of both low- and high-risk early-stage endometrial cancer. It has a high detection rate, high sensitivity, high negative predictive value, and low false negative rate in detection of lymph node metastasis. Cervical injection of indocyanine green for SLNM is the preferred method. SLNM reduces the number of lymph node removal and reduces complications from lymphadenectomy without compromising oncological safety. This review discusses the latest evidence of SLNM in endometrial cancer staging in terms of technique, accuracy, limitations, impact on lymphadenectomy complications, and cancer survival.
Hong Kong J Gynaecol Obstet Midwifery 2022; 22(2):114-24
  Copyright © 2022 by the Obstetrical & Gynaecological Society of Hong Kong
  and the Hong Kong Midwives Association
  Print ISSN:1608-9367
  Online ISSN:2225-904X
  This website is developed and maintained by
  the HKAM Press